Identification of a stress-sensitive endogenous opioid-containing neuronal population in the paranigral ventral tegmental area
Nociceptin/orphanin FQ (N/OFQ), an endogenous opioid neuropeptide, and its G-protein coupled receptor NOPR have been implicated in motivation, feeding behaviors, and aversion. Stress-induced dysfunction in these states is central to the development of numerous psychiatric disorders, and the N/OFQ-NOPR system's role in reward- and stress-related responses has driven broad interest in NOPR as a therapeutic target for anxiety and depression. However, the impact of stress on N/OFQ signaling in the context of its influence on discrete midbrain reward circuitry remains unknown. To this end, we focused on a possible candidate population of N/OFQ neurons in the paranigral ventral tegmental area (pnVTA<sup>PNOC</sup>) that have been shown to act locally on NOPR-containing VTA dopamine neurons to suppress motivation. Here we report and characterize pnVTA<sup>PNOC</sup> sensitivity during exposure to a diverse range of stressors. Our results indicate that pnVTA<sup>PNOC</sup> neurons become recruited during exposure to a variety of acute stressor types, suggesting that this N/OFQ population in the pnVTA could act as a critical bridge between stress and motivation.
Authors
- J. P. Johnson (ORCID: https://orcid.org/0000-0002-5762-5138)
- Amanda Loren Pasqualini (ORCID: https://orcid.org/0000-0002-0196-4827)
- Carrie Louise Stine
- David J. Marcus (ORCID: https://orcid.org/0000-0002-0767-4249)
- Michael R. Bruchas (ORCID: https://orcid.org/0000-0003-4039-4908)
- Sanjana Jadhav
- Ananya S. Achanta
Institutions
- University of Washington (US)
Publication Details
- Journal
- Neuropsychopharmacology
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1038/s41386-025-02292-z
- Primary Topic
- Neuropeptides and Animal Physiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Edward Mallinckrodt, Jr. Foundation
- National Institutes of Health
- National Institute of Mental Health
- National Institute on Drug Abuse